BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21714766)

  • 1. MLL-SEPTIN gene fusions in hematological malignancies.
    Cerveira N; Bizarro S; Teixeira MR
    Biol Chem; 2011 Aug; 392(8-9):713-24. PubMed ID: 21714766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression pattern of the septin gene family in acute myeloid leukemias with and without MLL-SEPT fusion genes.
    Santos J; Cerveira N; Bizarro S; Ribeiro FR; Correia C; Torres L; Lisboa S; Vieira J; Mariz JM; Norton L; Snijder S; Mellink CH; Buijs A; Shih LY; Strehl S; Micci F; Heim S; Teixeira MR
    Leuk Res; 2010 May; 34(5):615-21. PubMed ID: 19748670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural and expression changes of septins in myeloid neoplasia.
    Cerveira N; Santos J; Teixeira MR
    Crit Rev Oncog; 2009; 15(1-2):91-115. PubMed ID: 20136629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of Sept6, a fusion partner gene of MLL, does not affect ontogeny, leukemogenesis induced by MLL-SEPT6, or phenotype induced by the loss of Sept4.
    Ono R; Ihara M; Nakajima H; Ozaki K; Kataoka-Fujiwara Y; Taki T; Nagata K; Inagaki M; Yoshida N; Kitamura T; Hayashi Y; Kinoshita M; Nosaka T
    Mol Cell Biol; 2005 Dec; 25(24):10965-78. PubMed ID: 16314519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The versatile mixed lineage leukaemia gene MLL and its many associations in leukaemogenesis.
    Daser A; Rabbitts TH
    Semin Cancer Biol; 2005 Jun; 15(3):175-88. PubMed ID: 15826832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SEPT2 is a new fusion partner of MLL in acute myeloid leukemia with t(2;11)(q37;q23).
    Cerveira N; Correia C; Bizarro S; Pinto C; Lisboa S; Mariz JM; Marques M; Teixeira MR
    Oncogene; 2006 Oct; 25(45):6147-52. PubMed ID: 16682951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A variant-type MLL/SEPT9 fusion transcript in adult de novo acute monocytic leukemia (M5b) with t(11;17)(q23;q25).
    Kurosu T; Tsuji K; Ohki M; Miki T; Yamamoto M; Kakihana K; Koyama T; Taniguchi S; Miura O
    Int J Hematol; 2008 Sep; 88(2):192-196. PubMed ID: 18642054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Septin roles in tumorigenesis.
    Connolly D; Abdesselam I; Verdier-Pinard P; Montagna C
    Biol Chem; 2011 Aug; 392(8-9):725-38. PubMed ID: 21740328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed lineage leukemia: roles in human malignancies and potential therapy.
    Marschalek R
    FEBS J; 2010 Apr; 277(8):1822-31. PubMed ID: 20236311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and clinical characterization of 45 acute leukemia patients with MLL gene rearrangements from a single institution.
    Cerveira N; Lisboa S; Correia C; Bizarro S; Santos J; Torres L; Vieira J; Barros-Silva JD; Pereira D; Moreira C; Meyer C; Oliva T; Moreira I; Martins Â; Viterbo L; Costa V; Marschalek R; Pinto A; Mariz JM; Teixeira MR
    Mol Oncol; 2012 Oct; 6(5):553-64. PubMed ID: 22846743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukemogenic MLL fusion proteins bind across a broad region of the Hox a9 locus, promoting transcription and multiple histone modifications.
    Milne TA; Martin ME; Brock HW; Slany RK; Hess JL
    Cancer Res; 2005 Dec; 65(24):11367-74. PubMed ID: 16357144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of Ras-dependent Elk-1 activity by MLL-AF4 family fusion oncoproteins.
    Ng MH; Ng RK; Kong CT; Jin DY; Chan LC
    Exp Hematol; 2010 Jun; 38(6):481-8. PubMed ID: 20362031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rearrangements of the mixed lineage leukemia gene in acute myeloid leukemia].
    Zhang LJ; Lu XL; He J; Li Y
    Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(32):2256-60. PubMed ID: 17064570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The reciprocal world of MLL fusions: A personal view.
    Marschalek R
    Biochim Biophys Acta Gene Regul Mech; 2020 Jul; 1863(7):194547. PubMed ID: 32294539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of the MLL-SEPT6 fusion gene in acute myeloid leukemia: identification of novel fusion transcripts and cloning of genomic breakpoint junctions.
    Cerveira N; Micci F; Santos J; Pinheiro M; Correia C; Lisboa S; Bizarro S; Norton L; Glomstein A; Asberg AE; Heim S; Teixeira MR
    Haematologica; 2008 Jul; 93(7):1076-80. PubMed ID: 18492691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A t(11;15) fuses MLL to two different genes, AF15q14 and a novel gene MPFYVE on chromosome 15.
    Chinwalla V; Chien A; Odero M; Neilly MB; Zeleznik-Le NJ; Rowley JD
    Oncogene; 2003 Mar; 22(9):1400-10. PubMed ID: 12618766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both SEPT2 and MLL are down-regulated in MLL-SEPT2 therapy-related myeloid neoplasia.
    Cerveira N; Santos J; Bizarro S; Costa V; Ribeiro FR; Lisboa S; Correia C; Torres L; Vieira J; Snijder S; Mariz JM; Norton L; Mellink CH; Buijs A; Teixeira MR
    BMC Cancer; 2009 May; 9():147. PubMed ID: 19445675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights from clinical studies into the role of the MLL gene in infant and childhood leukemia.
    Chowdhury T; Brady HJ
    Blood Cells Mol Dis; 2008; 40(2):192-9. PubMed ID: 17905612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome translocations: good genes gone wrong.
    Rowley JD
    Pathol Biol (Paris); 1995 Mar; 43(3):197-201. PubMed ID: 7675546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic Classification of Mixed-Lineage Leukemia Fusion Partners Predicts Additional Cancer Pathways.
    Marschalek R
    Ann Lab Med; 2016 Mar; 36(2):85-100. PubMed ID: 26709255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.